Professor and Director of Hematologic Malignancies Translational Research Center
Hematology
Dr. James L. Ferrara, MD
|
|
Give Review
James L. Ferrara, MD practices Hematology. He studied medicine at Georgetown University School of Medicine. Georgetown University School of Medicine is ranked 49 in research and 84 in primary care medicine He has 32 awards "Ward-Coleman Chair in Cancer Medicine", "Nobel Lecture", "E. Donnell Thomas Lecturer", "Visiting Fellowship", "Dr. Lyonel G. Israels Visiting Professor", "Ruth Heyn Endowed Professor of Pediatric Oncology", "Doctor of Medicine, honoris causa", "Doctor of Science", "IBC Top 100 Health Professionals Citation", "American Cancer Society Clinical Research Professor", "Americas Top Physicians Citation", "Chairman", "Americas Top Pediatricians (Hematology/Oncology) Citation", "Member, Board of Trustees", "Whos Who", "Americas Top Doctors for Cancer (1st Edition) Citation", "Senior Fellow", "Member", "Doris Duke Distinguished Clinical Scientist Award", "Outstanding Clinician Award", "Alexander von Humboldt Research Prize", "Americas Top Doctors Citation", "Elected Member", "Scholar Award", "Junior Faculty Research Award", "Claudia Adams Barr Investigator", "Perini Foundation Fellow", "Von L. Meyer Fellowship", "Valedictorian", "Presidential Scholar", "Pediatric Award" and "Fredin Memorial Scholarship". James Ferrara is a published doctor. He has 26 publications published. The most current publication "Combination Therapy for GVHD Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial."
Publications
- Combination Therapy for GVHD Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.
- Reducing Treatment-related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A Universi...
- A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality.
- The IL-33/ST2 axis augments effector T cell responses during acute GVHD.
- Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease.
- Etanercept plus Topical Corticosteroids as Initial Therapy for Grade One Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
- Engraftment Syndrome after Allogeneic Hematopoietic Cell Transplantation Predicts Poor Outcomes.
- Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome af...
- Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.
- Blood and Marrow Transplant Clinical Trials Network: Progress since the State of the Science Symposium 2007.
- Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell ...
- Effector T cells require fatty acid metabolism during murine graft-versus-host disease.
- ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.
- Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality.
- Advances in predicting acute GVHD.
- Have we made progress in the treatment of GVHD?
- Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation.
- Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.
- TNF-inhibition with etanercept for graft versus host disease prevention in high risk HCT: Lower TNFR1 levels correlate with better outcomes.
- Graft-versus-host disease.
- A biomarker panel for acute graft-versus-host disease.
- The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantat...
- Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H.
- Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
- Improved accuracy of acute graft-versus-host disease staging among multiple centers.
Schools
Georgetown University
Children39s Hospital Boston
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Neutropenia
Doctors Specialties
- Hematology
Accepted Insurances
- Choice Plus POS II
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Health Alliance
- Choice Care PPO
- Medicaid
- Medicare MCR
Awards
- Ward-Coleman Chair in Cancer Medicine
- Nobel Lecture
- E. Donnell Thomas Lecturer
- Visiting Fellowship
- Dr. Lyonel G. Israels Visiting Professor
- Ruth Heyn Endowed Professor of Pediatric Oncology
- Doctor of Medicine, honoris causa
- Doctor of Science
- IBC Top 100 Health Professionals Citation
- American Cancer Society Clinical Research Professor
- America’s Top Physicians Citation
- Chairman
- America’s Top Pediatricians (Hematology/Oncology) Citation
- Member, Board of Trustees
- Who’s Who
- America’s Top Doctors for Cancer (1st Edition) Citation
- Senior Fellow
- Member
- Doris Duke Distinguished Clinical Scientist Award
- Outstanding Clinician Award
- Alexander von Humboldt Research Prize
- America’s Top Doctors Citation
- Elected Member
- Scholar Award
- Junior Faculty Research Award
- Claudia Adams Barr Investigator
- Perini Foundation Fellow
- Von L. Meyer Fellowship
- Valedictorian
- Presidential Scholar
- Pediatric Award
- Fredin Memorial Scholarship
Education
-
Boston Children's Hospital -
Georgetown University School of Medicine -
Georgetown University
Hospital
-
Mount Sinai Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Siraj M. El Jamal, MD |
|
|
Dr. Carlos E. Mendez, MD |
|
|
Dr. Mina S. Hanna, MD |
|
|
Dr. Hrvoje Melinscak, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evan M. Braunstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine J. Lee, MD |
|
|
Dr. Isaac A. Bowman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Schneider, MD |